Reviva Pharmaceuticals Warrants
RVPHW
RVPHW was delisted on the 12th of December, 2025.
3 hedge funds and large institutions have $203K invested in Reviva Pharmaceuticals Warrants in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
0.05% less ownership
Funds ownership: 0.69% → 0.64% (-0.05%)
15% less capital invested
Capital invested by funds: $240K → $203K (-$36.4K)
25% less funds holding
Funds holding: 4 → 3 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$17.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AI
1
Arena Investors
Purchase,
New York
| $118K | – | – | – |
|
2
Walleye Capital
New York
| $48.2K | – | – | – |
|
3
Walleye Trading
New York
| $36.8K | – | – | – |
|
|
BRWA
4
B. Riley Wealth Advisors
Boca Raton,
Florida
| – | -$17.1K | -11,101 | Closed |
|
RVPHW Hedge Fund Activity: Q4 2023 in Review
3 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Reviva Pharmaceuticals Warrants (RVPHW) for Q4 2023, worth a combined $203K — down 15% from $240K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of RVPHW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was B. Riley Wealth Advisors, exiting entirely with an estimated $17.1K sold.
- 3 institutional investors held Reviva Pharmaceuticals Warrants (RVPHW) as of Q4 2023, down from 4 in Q3 2023.
- Funds reported $203K of Reviva Pharmaceuticals Warrants stock for Q4 2023, down 15% quarter-over-quarter.
- 0 funds opened new Reviva Pharmaceuticals Warrants positions in Q4 2023 and 1 closed out, a net change of -1 holder.
- The largest Reviva Pharmaceuticals Warrants seller in Q4 2023 was B. Riley Wealth Advisors, an estimated $17.1K sold.
Based on aggregated 13F filings for Q4 2023.